Skip to main navigation Skip to search Skip to main content

A Phase I Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients with Solid Malignancies

Project: Research

Project Details

StatusFinished
Effective start/end date11/28/0506/11/10

Funding

  • Eisai Medical Research Inc and its Affiliates: $272,815.88